Chronic hypoxia enhances 15-lipoxygenase-mediated vasorelaxation in rabbit arteries

Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H678-88. doi: 10.1152/ajpheart.00777.2008. Epub 2008 Dec 26.

Abstract

15-Lipoxygenase (15-LO-1) metabolizes arachidonic acid (AA) to 11,12,15-trihydroxyeicosatrienoic acids (THETAs) and 15-hydroxy-11,12-epoxyeicosatrienoic acids (HEETA) that dilate rabbit arteries. Increased endothelial 15-LO-1 expression enhances arterial relaxations to agonists. We tested the effect of hypoxia on 15-LO-1 expression, THETA and HEETA synthesis, and relaxations in rabbit arteries. The incubation of rabbit aortic endothelial cells and isolated aortas in 0.7% O(2) increased 15-LO-1 expression. Rabbits were housed in a hypoxic atmosphere of 12% O(2) for 5 days. 15-LO-1 expression increased in the endothelium of the arteries of rabbits in 12% O(2) compared with room air. THETA and HEETA synthesis was also enhanced in aortas and mesenteric arteries. AA hyperpolarized the smooth muscle cells in indomethacin- and phenylephrine-treated mesenteric arteries of hypoxic rabbits from -29.4 +/- 1 to -50.1 +/- 3 mV. The hyperpolarization to AA was less in arteries of normoxic rabbits (from -26.0 +/- 2 to -37 +/- 2 mV). This AA-induced hyperpolarization was inhibited by the 15-LO inhibitor BW-755C. Nitric oxide and prostaglandin-independent maximum relaxations to acetylcholine (79.7 +/- 2%) and AA (38.3 +/- 4%) were enhanced in mesenteric arteries from hypoxic rabbits compared with the normoxic rabbits (49.7 +/- 6% and 19.9 +/- 2%, respectively). These relaxations were inhibited by BW-755C and nordihydroguaiaretic acid. Therefore, hypoxia increased the relaxations to agonists in the rabbit mesenteric arteries by enhancing endothelial 15-LO-1 expression and synthesis of the hyperpolarizing factors THETA and HEETA.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Retracted Publication

MeSH terms

  • 8,11,14-Eicosatrienoic Acid / analogs & derivatives
  • 8,11,14-Eicosatrienoic Acid / metabolism
  • Animals
  • Arachidonate 15-Lipoxygenase / genetics
  • Arachidonate 15-Lipoxygenase / metabolism*
  • Arachidonic Acid / metabolism
  • Arteries / drug effects
  • Arteries / enzymology*
  • Arteries / physiopathology
  • Biological Factors / metabolism
  • Cyclooxygenase Inhibitors / pharmacology
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular / enzymology
  • Endothelium, Vascular / physiopathology
  • Hypoxia / enzymology*
  • Hypoxia / pathology
  • Hypoxia / physiopathology
  • Lipoxygenase Inhibitors / pharmacology
  • Male
  • Membrane Potentials
  • Muscle, Smooth, Vascular / enzymology
  • Muscle, Smooth, Vascular / physiopathology
  • Nitric Oxide / metabolism
  • RNA, Messenger / metabolism
  • Rabbits
  • Time Factors
  • Tunica Intima / pathology
  • Vasoconstriction
  • Vasoconstrictor Agents / pharmacology
  • Vasodilation* / drug effects
  • Vasodilator Agents / pharmacology

Substances

  • 15-hydroxy-11,12-epoxyeicosatrienoic acid
  • Biological Factors
  • Cyclooxygenase Inhibitors
  • Lipoxygenase Inhibitors
  • RNA, Messenger
  • Vasoconstrictor Agents
  • Vasodilator Agents
  • endothelium-dependent hyperpolarization factor
  • Arachidonic Acid
  • Nitric Oxide
  • 11,12,15-trihydroxyeicosatrienoic acid
  • Arachidonate 15-Lipoxygenase
  • 8,11,14-Eicosatrienoic Acid